thiazoles has been researched along with Bipolar Disorder in 166 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.60) | 18.7374 |
| 1990's | 3 (1.81) | 18.2507 |
| 2000's | 84 (50.60) | 29.6817 |
| 2010's | 76 (45.78) | 24.3611 |
| 2020's | 2 (1.20) | 2.80 |
| Authors | Studies |
|---|---|
| Biederman, J; Cook, E; DiSalvo, M; Faraone, SV; Farrell, A; Joshi, G; Wozniak, J; Yule, A | 1 |
| Alexander, KM; Caposole, MZ; Ficarino, HM; Kinnard, CM; McGowin, EF; N Krebsbach, M; Noelle Davis, S; Simmons, JD | 1 |
| Filipe, TP; Marques, JG | 1 |
| Carvalho, AF; Hidalgo-Mazzei, D; Murru, A; Pacchiarotti, I; Samalin, L; Verdolini, N; Vieta, E; Young, AH | 1 |
| Dal-Pont, GC; Menegas, S; Peterle, BR; Quevedo, J; Resende, WR; Trajano, KS; Valvassori, SS; Varela, RB | 1 |
| Calabrese, JR; Gao, K; Karayal, ON; Kolluri, S; Pappadopulos, E | 1 |
| Bahk, WM; Kim, MD; Kwon, YJ; Lee, HB; Lee, JG; Woo, YS; Yoon, BH | 1 |
| Altamura, AC; Buoli, M; Serati, M | 1 |
| Cavuş, I; DelBello, MP; Findling, RL; Gundapaneni, BK; Pappadopulos, E; Schwartz, JH; Vanderburg, DG | 1 |
| Han, TY; Kim, EJ; Kim, MS; Kim, SW; Lee, JH; Son, SJ | 1 |
| Cucchiaro, J; Hsu, J; Kroger, H; Loebel, A; Sachs, G; Sarma, K; Silva, R | 1 |
| Calabrese, JR; Cucchiaro, J; Kroger, H; Loebel, A; Sarma, K; Silva, R; Xu, J | 1 |
| Belmaker, RH | 1 |
| Cha, DS; Kim, RD; Mansur, RB; McIntyre, RS | 1 |
| Citrome, L; Cucchiaro, J; Ketter, TA; Loebel, A | 1 |
| Cosgrove, VE; Feldman, NS; Gwizdowski, IS; Hidalgo, RB; McElroy, SL; Sheehan, DV; Suppes, T | 1 |
| Chennoufi, L; Cheour, M; Ouanes, S | 1 |
| Alamo, C; García-García, P; López-Muñoz, F | 1 |
| Ketter, TA | 1 |
| Jiang, Y; McGinnis, JJ; Ni, W | 1 |
| Dunlop, BW | 1 |
| Cornelius, V; Smith, L; Taylor, DM; Young, AH | 1 |
| McElroy, SL | 1 |
| Citrome, L | 4 |
| Mandrioli, R; Mercolini, L; Protti, M | 1 |
| Alarcon, RD; Biernacka, JM; Bobo, WV; Choi, DS; Frye, MA; Kung, S; Moore, KM; Prieto, ML; Tye, SJ; Veldic, M | 1 |
| Calabrese, JR; Citrome, L; Dell'Osso, B; Frye, MA; Ketter, TA; Miller, S | 1 |
| Calabrese, JR; Carta, MG; Moro, MF; Nardi, AE | 1 |
| Ketter, TA; Miller, S; Wang, PW | 1 |
| Cucchiaro, J; Kroger, H; Loebel, A; McIntyre, RS; Pikalov, A | 1 |
| Dalley, S; Ghaemi, SN; Loebel, A; Masand, PS; Mauer, S; Narasimhan, M; Pae, CU; Patkar, AA; Vöhringer, PA | 1 |
| Eddings, W; Franklin, JM; Kesselheim, AS; Landon, J; Wang, B | 1 |
| Alessandra, A; Daniela, C; Elisa, M; Giuseppina, D; Maria, N; Paolo, C; Perna, G; Raffaele, B | 1 |
| Carvalho, AF; Dal-Pont, GC; de Souza, CT; Farias, HR; Jornada, LK; Machado, AG; Peterle, BR; Quevedo, J; Resende, WR; Valvassori, SS | 1 |
| Hamera, L; Khishfe, BF | 1 |
| Lee, Y; Mansur, RB; McIntyre, RS | 1 |
| Chang, KD | 1 |
| Croarkin, PE; Emslie, GJ; Mayes, TL | 1 |
| DelBello, MP; Ice, K; Keller, D; Miceli, J; Versavel, M | 1 |
| Kang, SG; Kim, H; Lee, HJ; Lee, KJ; Lee, SH; Park, YM | 1 |
| Alderman, JA; Gandelman, K; Glue, P; LaBadie, RR; Lombardo, I; Preskorn, SH; Versavel, M | 1 |
| Benabarre, A; Comes, M; Cruz, N; Franco, C; Horga, G; Rosa, AR; Torrent, C; Vieta, E | 1 |
| English, PA; Keller, D; Loebel, AD; Miceli, J; Ramey, T; Vieta, E | 1 |
| Boora, K; Chiappone, K; Dubovsky, S; Xu, J | 1 |
| Akhtar, J; Dunner, D; Johnson, AE; Liebowitz, MR; Mech, A; Pratap, R; Salmán, E | 1 |
| Jing, Y; Kim, E; Pikalov, A; Tran, QV; You, M | 1 |
| Horne, RL; Keck, PE; Loebel, AD; Versiani, M; Warrington, L | 1 |
| Endicott, JM; Harvey, PD; Loebel, AD | 1 |
| Loebel, A; Lombardo, I; Mandel, FS; Stahl, S | 1 |
| Citrome, L; Jaffe, A; Levine, J | 1 |
| Bastiampillai, T; Dhillon, R; Mohan, T | 1 |
| Agid, O; Kapur, S; Ketter, TA; Loebel, A; Romano, SJ; Siu, CO | 1 |
| Kuehn, BM | 1 |
| Loebel, AD; Meyer, JM; Schweizer, E | 1 |
| Citrome, L; Cuffel, B; Harnett, J; Lenhart, G; Montejano, LB; Palmer, L; Reist, C; Sanders, KN | 1 |
| Duggal, HS; Singh, I | 2 |
| Chandra, AB; Chandra, PA | 1 |
| DelBello, MP; Keller, D; Stewart, M; Versavel, M | 1 |
| Chen, L; Pym, H | 1 |
| Alipour, A; Cruz, R; Lott, RS | 1 |
| Bowden, CL; Ice, KS; Schwartz, JH; Versavel, M; Vieta, E; Wang, PP | 1 |
| Pennell, K; Spiegel, DR; Turner, K; Weller, AL | 1 |
| Barth, KS; Garner, A; Phan, SV; Snarr, BS; VandenBerg, AM | 1 |
| Lincoln, J; Preskorn, SH; Stewart, ME | 1 |
| Blumenthal, R; Drevets, W; Du, J; Hunsberger, JG; Khairova, R; Liu, L; Machado-Vieira, R; Manji, HK; Tragon, T; Wang, Y; Wang, YT; Wei, Y | 1 |
| ASSAILLY, AA; DELAY, J | 1 |
| Dawson, LA; Kalinichev, M | 1 |
| Chandler, RA; Childers, ME; Hill, SJ; Ketter, TA; Rasgon, NL; Wang, PW | 1 |
| Dubovsky, AN; Dubovsky, SL | 1 |
| Lombardo, I; Mandel, FS; Pappadopulos, E; Vieta, E | 1 |
| Howland, RH | 1 |
| Anway, SD; Batzar, E; Karayal, ON; Vanderburg, DG | 1 |
| Baldaçara, L; Cordeiro, DC; Jackoswski, AP; Sanches, M | 1 |
| Chappell, PB; Gurtovaya, O; Ice, KS; Kasuba, B; Sachs, GS; Schwartz, JH; Vanderburg, DG | 1 |
| Calabrese, JR; Ice, KS; Karayal, ON; Kemp, DE; Pappadopulos, E; Sachs, GS; Siu, CO; Vieta, E | 1 |
| Cañas, F; Correll, CU; Fagiolini, A; Larmo, I; Levy, P; Montes, JM; Papageorgiou, G; Rossi, A; Zink, M | 1 |
| Galluzzo, A; Sacchetti, E; Valsecchi, P | 1 |
| Bobo, WV; Chen, Y; Jayathilake, K; Meltzer, HY; Tang, T; Watts, K | 1 |
| Camm, AJ; Kane, JM; Karayal, ON; Kolluri, S; Meltzer, H; Miceli, J; O'Gorman, C; Tensfeldt, T | 1 |
| Filkowski, MM; Ghaemi, SN; Gilmer, W; Holtzman, NS; Loebel, A; Logvinenko, T; Masand, P; Mulligan, M; Pae, CU; Patkar, A; Pirok, E; Thommi, SB; Vöhringer, PA; Whitham, EA; Ziffra, M | 1 |
| Alsuwaidan, M; Cha, DS; Jerrell, JM; McIntosh, D; McIntyre, RS; Powell, AM | 1 |
| Chen, SC; Gordon, JS; Neyman, KM; Wells, RD | 1 |
| Kolluri, S; Kremer, C; Lombardo, I; Sachs, G; Yang, R | 1 |
| Kolluri, S; Newcomer, JW; Pappadopulos, E | 1 |
| Adler, CM; Bitter, SM; DelBello, MP; Eliassen, J; Mills, NP; Schneider, MR; Strakowski, SM; Weber, W; Whitsel, R | 1 |
| Stahl, SM; Tarazi, FI | 1 |
| Alvir, JM; Berger, A; Edelsberg, J; Mychaskiw, MA; Oster, G; Sanders, KN | 1 |
| Correll, CU; De Hert, M; Detraux, J; Sweers, K; van Winkel, R; Yu, W | 1 |
| Bowden, CL; Gundapaneni, BK; Karayal, ON; O'Gorman, C; Schwartz, JH | 1 |
| Mandel, FS; Masand, PS; O'Gorman, C; Pae, CU | 1 |
| Capapey, J; Colom, F; Goikolea, JM; Grande, I; Sanchez-Moreno, J; Torres, I; Undurraga, J; Valentí, M; Vieta, E | 1 |
| Childers, ME; Hill, SJ; Ittasakul, P; Ketter, TA; Miller, S; Rasgon, N; Wang, PW | 1 |
| Bachinsky, M; Cavus, I; Karayal, ON; Kolluri, S; Sachs, GS; Vanderburg, DG | 1 |
| Bachinsky, M; Cavus, I; Edman, S; Karayal, ON; Kolluri, S; Sachs, GS; Vanderburg, DG | 1 |
| Tohen, M | 1 |
| Ghaemi, SN; Rosenquist, KJ; Walker, SS | 1 |
| Escalona, PR; Lu, BY; Lundgren, R; Roberts, BB | 1 |
| Baldassano, CF; Ballas, C; Datto, SM; Kim, D; Littman, L; O'Reardon, J; Rynn, MA | 1 |
| Giller, E; Ice, K; Keck, PE; Potkin, S; Versiani, M; West, SA | 1 |
| Nolan, BP; Schulte, JJ | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Alessi, NE | 1 |
| Hauser, A; Larson, MF | 1 |
| Maharaj, K; Privitera, MR | 1 |
| Brieger, P | 1 |
| Kawai, M; Minabe, Y; Mori, N; Takei, N; Tani, K; Yokoshima, T | 1 |
| Coffey, B | 1 |
| Burdick, KE; Endick, CJ; Goldberg, JF | 1 |
| Levy, WO; Nunez, CY | 1 |
| Cremonese, E; Garrido, R | 1 |
| Findling, RL; McNamara, NK | 1 |
| Barnett, MS | 2 |
| Charney, DS; Denicoff, KD; Luckenbaugh, DA; Manji, HK; Payne, JL; Quiroz, JA; Singh, J; Zarate, CA | 1 |
| Ross, DE | 1 |
| Andrade, C | 1 |
| Cancro, R; Chuang, L; Jacobson, J; Lusskin, SI | 1 |
| Durkin, JP | 1 |
| Friedrich, MJ | 1 |
| Vieta, E | 1 |
| Althoff, R; Jacobson, J; Martineau, RJ; Singh, A | 1 |
| Goikolea, JM; Vieta, E | 1 |
| Benabarre, A; Bernardo, M; Prieto, T | 1 |
| English, P; Ice, K; Keck, PE; Potkin, SG; Segal, S | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Geddes, J | 1 |
| Hwang, J; Kaufman, KR; Mohebati, A; Olsavsky, A; Stern, L | 1 |
| Bitter, I; Jones, RM; Thompson, C | 1 |
| Altinbas, K; Demirkiran, S; Oral, ET | 1 |
| Gianfrancesco, FD; Rajagopalan, K; Sajatovic, M; Wang, RH | 1 |
| Adler, CM; Strakowski, SM; Weinstein, SK | 1 |
| Frank, B; Gupta, S; Vincent, JL | 1 |
| Alvarez, E; Barrachina, J; Campins, MJ; Madre, M; Pascual, JC; Pérez, V; Soler, J | 1 |
| Versiani, M | 1 |
| Cannon, DM; Carson, RE; Drevets, M; Drevets, WC; Eckelman, WC; Gandhi, S; Kiesewetter, DO; Nugent, AC; Rollis, D; Solorio, G; Williams, J | 1 |
| Ehret, MJ; Levin, GM | 1 |
| Keck, PE; Patel, NC | 1 |
| Coffey, B; Jummani, R; Vito, J | 1 |
| Correll, CU; Frederickson, AM; Kane, JM; Manu, P | 1 |
| Mellacheruvu, S; Norton, JW; Schweinfurth, J | 1 |
| Gianfrancesco, F; Goldberg, JF; Rajagopalan, K; Wang, RH | 1 |
| Citrome, L; Greenberg, WM | 1 |
| Ice, K; Loebel, A; Lombardo, I; Warrington, L | 1 |
| Varma, A; Wickham, R | 1 |
| Jain, R; Skale, TG | 1 |
| Perlis, RH | 1 |
| Aleardi, M; Biederman, J; Dougherty, M; Mick, E; Spencer, T; Wozniak, J | 1 |
| Calabrese, JR; Gajwani, P; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ | 1 |
| Alvarez, E; Pascual, JC; Pérez, V; Pérez-Egea, R; Puigdemont, D; Soler, J; Tiana, T | 1 |
| Citil, DY; Karlidağ, R; Selçuk, E; Unal, S | 1 |
| Mech, AW | 1 |
| Kane, JM | 1 |
| Dunn, RT; Frye, MA; Goldberg, JF | 1 |
| Fredman, SJ; Rosenbaum, JF | 1 |
| Fava, M; Ghaemi, SN; Rankin, MA; Recht, J; Rosenbaum, JF; Sachs, GS; Sambur, MR; Sporn, J | 1 |
| Carnahan, RM; Lund, BC; Perry, PJ | 1 |
| Akiskal, H; Frare, F; Perugi, G; Ruffolo, G; Toni, C | 1 |
| Weizman, A; Weizman, R | 1 |
| Ostow, M | 1 |
| Gutierrez, MA; Lee, V; Stimmel, GL | 1 |
| McIntyre, RS | 1 |
| Davis, R; Risch, SC | 1 |
50 review(s) available for thiazoles and Bipolar Disorder
| Article | Year |
|---|---|
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Lithium; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2018 |
Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia.
Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Sleep Stages; Thiazoles; Weight Gain | 2013 |
The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Substitution; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Lithium; Male; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2013 |
Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy, Combination; Humans; Long-Term Care; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2014 |
A review of FDA-approved treatment options in bipolar depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Bipolar Disorder; Central Nervous System Stimulants; Depressive Disorder; Dibenzothiazepines; Drug Approval; Drug Combinations; Excitatory Amino Acid Antagonists; Fluoxetine; Humans; Isoindoles; Ketamine; Lamotrigine; Lurasidone Hydrochloride; Modafinil; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Thiazoles; Triazines; United States; United States Food and Drug Administration | 2013 |
Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Topics: Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Isoindoles; Lurasidone Hydrochloride; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Thiazoles; Treatment Outcome | 2014 |
An update on the treatment of mixed bipolar states: what is new in 2013?
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Calcitonin; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Olanzapine; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome | 2014 |
The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder.
Topics: Antimanic Agents; Bipolar Disorder; Drug Therapy, Combination; Humans; Isoindoles; Lithium; Lurasidone Hydrochloride; Thiazoles; Treatment Outcome; Valproic Acid | 2014 |
Acute and maintenance treatments for bipolar depression.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lurasidone Hydrochloride; Olanzapine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2014 |
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid | 2014 |
Treatment of bipolar depression: making sensible decisions.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Dibenzothiazepines; Drug Combinations; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Quetiapine Fumarate; Thiazoles; Valproic Acid | 2014 |
Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Disorders of Excessive Somnolence; Dizziness; Drug Evaluation; Humans; Piperazines; Schizophrenia; Thiazoles; Treatment Outcome | 2015 |
Current landscape, unmet needs, and future directions for treatment of bipolar depression.
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Fluoxetine; Forecasting; Health Services Needs and Demand; Humans; Isoindoles; Lamotrigine; Lurasidone Hydrochloride; Psychotherapy; Quetiapine Fumarate; Thiazoles; Triazines | 2014 |
Balancing benefits and harms of treatments for acute bipolar depression.
Topics: Acute Disease; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lurasidone Hydrochloride; Multicenter Studies as Topic; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiazoles; Triazines; Weight Gain | 2014 |
Potential use of lurasidone for the treatment of bipolar psychosis.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Humans; Isoindoles; Lurasidone Hydrochloride; Psychotic Disorders; Schizophrenia; Thiazoles | 2015 |
Bipolar therapeutics update 2014: A tale of 3 treatments.
Topics: Antipsychotic Agents; Benzhydryl Compounds; Bipolar Disorder; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Drug Discovery; Humans; Isoindoles; Lurasidone Hydrochloride; Modafinil; Piperazines; Thiazoles | 2015 |
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Panic Disorder; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2016 |
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disorders.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cognitive Behavioral Therapy; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Humans; Lithium Compounds; Mood Disorders; Piperazines; Thiazoles | 2016 |
The use of atypical antipsychotics in pediatric bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain | 2008 |
Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Child, Preschool; Clozapine; Dibenzothiazepines; Humans; Neuroleptic Malignant Syndrome; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles | 2008 |
Ziprasidone in the treatment of affective disorders: a review.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Piperazines; Randomized Controlled Trials as Topic; Thiazoles | 2008 |
Using oral ziprasidone effectively: the food effect and dose-response.
Topics: Administration, Oral; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Energy Intake; Food-Drug Interactions; Humans; Injections, Intramuscular; Intestinal Absorption; Piperazines; Safety; Schizophrenia; Thiazoles; Treatment Outcome | 2009 |
Lurasidone: a new drug in development for schizophrenia.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Clinical Trials, Phase II as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Isoindoles; Lurasidone Hydrochloride; Schizophrenia; Thiazoles | 2009 |
Ziprasidone HCl capsules for the adjunctive maintenance treatment of bipolar disorder in adults.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Piperazines; Randomized Controlled Trials as Topic; Thiazoles | 2010 |
Drug safety evaluation of ziprasidone.
Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Long QT Syndrome; Piperazines; Schizophrenia; Thiazoles | 2011 |
Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.
Topics: Acute Disease; Antipsychotic Agents; Bipolar Disorder; Humans; Molecular Structure; Piperazines; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Thiazoles | 2011 |
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.
Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Humans; Piperazines; Randomized Controlled Trials as Topic; Thiazoles; Treatment Outcome | 2011 |
Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bipolar Disorder; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Dose-Response Relationship, Drug; Electrocardiography; Humans; Long QT Syndrome; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles | 2012 |
A review of published evidence reporting on the efficacy and pharmacology of lurasidone.
Topics: Bipolar Disorder; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cognition Disorders; Double-Blind Method; Humans; Isoindoles; Lurasidone Hydrochloride; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles | 2012 |
Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials.
Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Body Weight; Clinical Trials as Topic; Drug Industry; Fasting; Humans; Lipids; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors | 2012 |
Iloperidone, asenapine and lurasidone: a primer on their current status.
Topics: Adult; Animals; Antipsychotic Agents; Bipolar Disorder; Dibenzocycloheptenes; Drug Approval; Heterocyclic Compounds, 4 or More Rings; Humans; Isoindoles; Isoxazoles; Lurasidone Hydrochloride; Piperidines; Schizophrenia; Thiazoles; United States; United States Food and Drug Administration | 2012 |
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Isoindoles; Isoxazoles; Lipid Metabolism; Lurasidone Hydrochloride; Paliperidone Palmitate; Piperidines; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Weight Gain | 2012 |
Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Industry; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Support as Topic; Risperidone; Thiazoles | 2013 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Atypical antipsychotics in the treatment of children and adolescents: clinical applications.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Benzodiazepines; Bipolar Disorder; Child; Child Development Disorders, Pervasive; Clozapine; Dibenzothiazepines; Humans; Mental Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Tic Disorders | 2004 |
The treatment of mixed states and the risk of switching to depression.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Electroconvulsive Therapy; Haloperidol; Health Education; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Thiazoles | 2005 |
Atypical antipsychotics: newer options for mania and maintenance therapy.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Humans; Lithium Carbonate; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles | 2005 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
Bipolar disorder.
Topics: Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Chlorpromazine; Cognitive Behavioral Therapy; Humans; Lithium Carbonate; Olanzapine; Piperazines; Thiazoles; Valproic Acid | 2005 |
A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2006 |
Long-term use of atypical antipsychotics in bipolar disorder.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Administration Schedule; Drug Costs; Humans; Olanzapine; Piperazines; Practice Guidelines as Topic; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; United States | 2006 |
Ziprasidone: efficacy and safety in patients with bipolar disorder.
Topics: Bipolar Disorder; Dopamine Antagonists; Humans; Piperazines; Thiazoles | 2006 |
Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.
Topics: Affective Symptoms; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Longitudinal Studies; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome | 2007 |
Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Dopamine D2 Receptor Antagonists; Humans; Piperazines; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Treatment Outcome | 2007 |
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Research Design; Risperidone; Schizophrenia; Sleep Stages; Thiazoles; Treatment Outcome | 2008 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome | 1999 |
Ziprasidone, a new atypical antipsychotic drug.
Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome | 2001 |
Use of atypical antipsychotics in mood disorders.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Clozapine; Depressive Disorder, Major; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles | 2001 |
Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.
Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Drug Overdose; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome | 2002 |
34 trial(s) available for thiazoles and Bipolar Disorder
| Article | Year |
|---|---|
Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Double-Blind Method; Female; Humans; Male; Piperazines; Thiazoles; Treatment Outcome | 2013 |
Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2014 |
Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Male; Middle Aged; Psychiatric Status Rating Scales; Thiazoles; Valproic Acid | 2014 |
A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
Topics: Adult; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Comorbidity; Double-Blind Method; Humans; Middle Aged; Panic Disorder; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome; Young Adult | 2014 |
Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
Topics: Adult; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Thiazoles | 2015 |
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2015 |
Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Thiazoles | 2008 |
The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial.
Topics: Adult; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Cross-Over Studies; Dietary Fats; Drug Administration Schedule; Energy Intake; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Young Adult | 2009 |
Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Female; Haloperidol; Humans; India; Male; Middle Aged; Patient Dropouts; Piperazines; Placebo Effect; Psychiatric Status Rating Scales; Russia; Thiazoles; Time Factors; Treatment Outcome; United States; Young Adult | 2010 |
Ziprasidone monotherapy in bipolar II depression: an open trial.
Topics: Adult; Affect; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Interview, Psychological; Male; Middle Aged; Personality Inventory; Piperazines; Psychometrics; Thiazoles; Treatment Outcome | 2009 |
Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Cohort Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2009 |
The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Patient Admission; Piperazines; Psychiatric Status Rating Scales; Psychometrics; Thiazoles | 2008 |
Rapid antipsychotic response with ziprasidone predicts subsequent acute manic/mixed episode remission.
Topics: Adult; Antipsychotic Agents; Area Under Curve; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; ROC Curve; Secondary Prevention; Thiazoles; Time Factors; Treatment Outcome | 2010 |
Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Status; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Social Behavior; Thiazoles; Treatment Outcome | 2009 |
Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome; Valproic Acid | 2010 |
Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Male; Midazolam; Olanzapine; Piperazines; Promethazine; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Tranquilizing Agents | 2011 |
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium; Male; Middle Aged; Piperazines; Serotonin Antagonists; Thiazoles; Treatment Outcome; Triazines; Valproic Acid; Young Adult | 2011 |
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.
Topics: Adjuvants, Immunologic; Antipsychotic Agents; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Longitudinal Studies; Male; Metabolic Diseases; Metabolome; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Valproic Acid | 2012 |
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Atherosclerosis; Bipolar Disorder; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Dyslipidemias; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; North America; Patient Dropouts; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Schizophrenia; Severity of Illness Index; Thiazoles; Weight Loss | 2012 |
A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2012 |
Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome?
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Outpatients; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2012 |
The effects of ziprasidone on prefrontal and amygdalar activation in manic youth with bipolar disorder.
Topics: Adolescent; Amygdala; Antipsychotic Agents; Bipolar Disorder; Child; Female; Humans; Magnetic Resonance Imaging; Male; Piperazines; Prefrontal Cortex; Thiazoles | 2012 |
Characterizing relapse prevention in bipolar disorder with adjunctive ziprasidone: clinical and methodological implications.
Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Lithium; Piperazines; Secondary Prevention; Thiazoles; Treatment Outcome; Valproic Acid | 2013 |
Achieving and sustaining remission in bipolar I disorder with ziprasidone : a post hoc analysis of a 24-week, double-blind, placebo-controlled study.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; Thiazoles; Time Factors; Treatment Outcome; Valproic Acid | 2012 |
Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Middle Aged; Obesity; Piperazines; Thiazoles; Treatment Outcome | 2012 |
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Antimanic Agents; Basal Ganglia Diseases; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.
Topics: Administration, Oral; Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Diagnosis, Computer-Assisted; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Interview, Psychological; Lithium Carbonate; Male; Middle Aged; Patient Selection; Piperazines; Psychiatric Status Rating Scales; Psychometrics; Research Design; Signal Detection, Psychological; Thiazoles; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles; Treatment Outcome | 2003 |
Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression.
Topics: Adult; Ambulatory Care; Anticonvulsants; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Personality Assessment; Pilot Projects; Pramipexole; Thiazoles | 2004 |
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Nerve Growth Factors; Pilot Projects; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Valproic Acid | 2004 |
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Treatment Outcome | 2005 |
A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder.
Topics: Antipsychotic Agents; Bipolar Disorder; Body Weight; Evaluation Studies as Topic; Female; Humans; Male; Pediatrics; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Thiazoles | 2007 |
Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Humans; Middle Aged; Neurocognitive Disorders; Piperazines; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders; Surveys and Questionnaires; Thiazoles | 2008 |
Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series.
Topics: Adult; Aged; Benzothiazoles; Bipolar Disorder; Depressive Disorder; Dopamine Agonists; Drug Resistance; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Pramipexole; Psychiatric Status Rating Scales; Thiazoles | 2001 |
82 other study(ies) available for thiazoles and Bipolar Disorder
| Article | Year |
|---|---|
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Child; Clinical Trials as Topic; Conduct Disorder; Humans; Mania; Olanzapine; Piperazines; Prospective Studies; Quetiapine Fumarate; Risperidone; Thiazoles | 2022 |
Neuroleptic Malignant Syndrome: A Potential Etiology of Multisystem Organ Failure in a Burn Patient.
Topics: Accidents, Occupational; Acute Coronary Syndrome; Adult; Antipsychotic Agents; Bipolar Disorder; Body Surface Area; Burns, Chemical; Calcium; Creatine Kinase; Humans; Hypocalcemia; Male; Multiple Organ Failure; Neuroleptic Malignant Syndrome; Piperazines; Tachycardia, Ventricular; Thiazoles; Troponin | 2022 |
Pleurothotonus (Pisa syndrome) Induced by an Association of Clozapine and Mirabegron.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Antipsychotic Agents; Bipolar Disorder; Clozapine; Drug Interactions; Dystonia; Female; Humans; Middle Aged; Posture; Thiazoles; Urinary Incontinence | 2018 |
Inhibition of GSK-3β on Behavioral Changes and Oxidative Stress in an Animal Model of Mania.
Topics: Aldehydes; Animals; Antioxidants; Behavior, Animal; Bipolar Disorder; Catalase; Dinoprost; Disease Models, Animal; Glutathione Peroxidase; Glycogen Synthase Kinase 3 beta; Lipid Peroxidation; Male; Motor Activity; Oxidative Stress; Protein Carbonylation; Rats, Wistar; Submitochondrial Particles; Superoxide Dismutase; Superoxides; Thiazoles; Tyrosine; Urea | 2019 |
Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Hypersensitivity Syndrome; Female; Humans; Piperazines; Recurrence; Retreatment; Thiazoles | 2014 |
Lurasidone and bipolar disorder.
Topics: Bipolar Disorder; Female; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Male; Thiazoles; Valproic Acid | 2014 |
Comparison of health services use associated with ziprasidone and olanzapine among schizophrenia and bipolar disorder patients in the USA.
Topics: Adult; Ambulatory Care; Benzodiazepines; Bipolar Disorder; Emergency Service, Hospital; Female; Health Care Costs; Health Services; Humans; Male; Middle Aged; Olanzapine; Piperazines; Schizophrenia; Thiazoles; United States | 2014 |
Ziprasidone monotherapy is ineffective for bipolar-associated anxiety.
Topics: Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Humans; Piperazines; Thiazoles | 2014 |
Pros and cons of approved therapies for bipolar depression and ongoing unmet needs.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Fluoxetine; Humans; Isoindoles; Lurasidone Hydrochloride; Quetiapine Fumarate; Thiazoles | 2014 |
Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Decision Making; Drug Approval; Drug Prescriptions; Female; Humans; Male; Middle Aged; Olanzapine; Pediatrics; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; United States; United States Food and Drug Administration | 2016 |
Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Disease Models, Animal; Frontal Lobe; Glycogen Synthase Kinase 3 beta; Hippocampus; Lithium Compounds; Locomotion; Male; Ouabain; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Thiazoles; Urea; Valproic Acid | 2017 |
Kounis syndrome and ziprasidone.
Topics: Acute Coronary Syndrome; Adult; Antipsychotic Agents; Bipolar Disorder; Drug Hypersensitivity; Emergency Service, Hospital; Humans; Male; Piperazines; Suicidal Ideation; Syndrome; Thiazoles | 2017 |
Ziprasidone-associated mania in Korean schizophrenic patient.
Topics: Adult; Antipsychotic Agents; Asian People; Bipolar Disorder; Humans; Korea; Male; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles | 2008 |
Ziprasidone-induced spontaneous orgasm.
Topics: Antipsychotic Agents; Bipolar Disorder; Female; Humans; Middle Aged; Orgasm; Piperazines; Sexual Dysfunctions, Psychological; Thiazoles; Torticollis | 2010 |
Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Costs and Cost Analysis; Dibenzothiazepines; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Middle Aged; Mood Disorders; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome; Young Adult | 2009 |
Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.
Topics: Acute Disease; Adult; Affect; Aged; Bipolar Disorder; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Thiazoles | 2010 |
How dosing of ziprasidone in a state hospital system differs from product labeling.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Female; Hospitalization; Hospitals, Psychiatric; Hospitals, State; Humans; Male; Piperazines; Prescription Drugs; Product Labeling; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome | 2009 |
Ziprasidone-induced angioedema: a case report.
Topics: Adult; Angioedema; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Piperazines; Thiazoles | 2009 |
FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Child; Dibenzothiazepines; Drug Approval; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; United States; United States Food and Drug Administration | 2009 |
Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; International Classification of Diseases; Male; Middle Aged; Piperazines; Probability; Propensity Score; Proportional Hazards Models; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome | 2009 |
New-onset vascular mania in a patient with chronic depression.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Dementia, Vascular; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2009 |
Brugada syndrome unmasked by lithium.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Brugada Syndrome; Cardiopulmonary Resuscitation; Drug Therapy, Combination; Electrocardiography; Heart Arrest; Heart Conduction System; Humans; Lamotrigine; Lithium Compounds; Male; Piperazines; Sodium Channel Blockers; Thiazoles; Triazines | 2009 |
Rapid onset of neurological symptoms and lithium toxicity on starting meloxicam.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Bipolar Disorder; Drug Interactions; Female; Humans; Lithium Compounds; Meloxicam; Middle Aged; Nervous System Diseases; Thiazines; Thiazoles | 2010 |
Torsade de pointes after ziprasidone overdose with coingestants.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Drug Overdose; Female; Humans; Long QT Syndrome; Middle Aged; Piperazines; Thiazoles; Torsades de Pointes | 2010 |
The successful treatment of mania due to acquired immunodeficiency syndrome using ziprasidone: a case series.
Topics: Acquired Immunodeficiency Syndrome; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Female; Humans; Middle Aged; Piperazines; Thiazoles; Treatment Outcome | 2010 |
Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bradycardia; Delusions; Electrocardiography; Female; Humans; Lithium Carbonate; Piperazines; Psychotic Disorders; Quinolones; Thiazoles | 2010 |
How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Biological Availability; Biomedical Research; Bipolar Disorder; Dietary Fats; Dose-Response Relationship, Drug; Drug Evaluation; Drug Monitoring; Drugs, Investigational; Energy Intake; Fasting; Female; Food-Drug Interactions; Humans; Intestinal Absorption; Male; Middle Aged; Piperazines; Postprandial Period; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2010 |
A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.
Topics: Affect; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antidepressive Agents; Bipolar Disorder; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Kinesins; Lithium; Male; Mice; Microtubule-Associated Proteins; Models, Biological; Neuronal Plasticity; Receptors, AMPA; Synapses; Thiazoles; Urea | 2010 |
Action of aminothiazol on the development of manic access.
Topics: Bipolar Disorder; Conversion Disorder; Hysteria; Mental Disorders; Neurosyphilis; Psychotic Disorders; Thiazoles | 1946 |
Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania.
Topics: Amphetamine; Animals; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Blood-Brain Barrier; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glycogen Synthase Kinase 3; Humans; Indoles; Male; Maleimides; Mice; Mice, Mutant Strains; Molecular Targeted Therapy; Motor Activity; Reproducibility of Results; Thiadiazoles; Thiazoles; Urea | 2011 |
Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Dose-Response Relationship, Drug; Fasting; Female; Humans; Male; Middle Aged; Obesity; Overweight; Piperazines; Prospective Studies; Thiazoles; Waist Circumference; Weight Loss | 2011 |
Ziprasidone for maintenance treatment of bipolar I disorder in adults.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Humans; Piperazines; Placebos; Randomized Controlled Trials as Topic; Thiazoles | 2011 |
Impact of geographical and cultural factors on clinical trials in acute mania: lessons from a ziprasidone and haloperidol placebo-controlled study.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Cultural Characteristics; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Health Status Disparities; Healthcare Disparities; Humans; India; Internationality; Male; Piperazines; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Research Design; Russia; Thiazoles; Treatment Outcome; United States; Young Adult | 2011 |
Update on newer antipsychotic drugs.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Child; Clinical Trials as Topic; Dibenzocycloheptenes; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Isoindoles; Isoxazoles; Lurasidone Hydrochloride; Male; Piperidines; Pregnancy; Schizophrenia; Thiazoles; Treatment Outcome | 2011 |
Assessments of suicidality in double-blind, placebo-controlled trials of ziprasidone.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Child; Confidence Intervals; Humans; Odds Ratio; Piperazines; Randomized Controlled Trials as Topic; Risk; Schizophrenia; Suicidal Ideation; Suicide; Suicide, Attempted; Thiazoles | 2011 |
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Eruptions; Drug Hypersensitivity; Eosinophilia; Female; Humans; Piperazines; Prednisone; Risk Factors; Syndrome; Thiazoles; Treatment Outcome | 2012 |
Medication adherence and utilization in patients with schizophrenia or bipolar disorder receiving aripiprazole, quetiapine, or ziprasidone at hospital discharge: a retrospective cohort study.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Databases, Factual; Dibenzothiazepines; Female; Humans; Male; Medication Adherence; Patient Discharge; Piperazines; Quetiapine Fumarate; Quinolones; Retrospective Studies; Schizophrenia; Thiazoles | 2012 |
Methodologies to avoid the enrollment of ineligible patients in clinical trials.
Topics: Antimanic Agents; Bipolar Disorder; Female; Humans; Lithium Carbonate; Male; Patient Selection; Piperazines; Signal Detection, Psychological; Thiazoles; Valproic Acid | 2012 |
Tardive dyskinesia and ziprasidone.
Topics: Antipsychotic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Piperazines; Recurrence; Risk Factors; Thiazoles | 2002 |
A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Piperazines; Psychotic Disorders; Serotonin; Thiazoles | 2002 |
Ziprasidone-associated mania: a case series and review of the mechanism.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2003 |
Mania associated with initiation of ziprasidone.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Humans; Male; Piperazines; Schizophrenia; Thiazoles | 2003 |
Ziprasidone in autism.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Bipolar Disorder; Comorbidity; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Thiazoles | 2003 |
Possible ziprasidone-induced mania.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Piperazines; Schizophrenia; Thiazoles | 2003 |
Mania from dose-related ziprasidone augmentation of an SSRI.
Topics: Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2003 |
Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Humans; Male; Piperazines; Psychotic Disorders; Thiazoles | 2004 |
Two cases of perospirone-induced mania in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Indoles; Isoindoles; Male; Schizophrenia; Thiazoles | 2004 |
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Diagnosis, Differential; Education; Family; GABA Modulators; Haloperidol; Hospitalization; Humans; Irritable Mood; Lithium; Lorazepam; Male; Piperazines; Psychiatric Status Rating Scales; Sexual Behavior; Thiazoles; Valproic Acid | 2003 |
Use of ziprasidone to treat bipolar-associated catatonia.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Catatonia; Female; Humans; Piperazines; Thiazoles | 2004 |
[Hypomania induced by Ziprasidone].
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Piperazines; Thiazoles | 2004 |
Ziprasidone and mania.
Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Humans; Piperazines; Thiazoles | 2004 |
Ziprasidone and mania.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Drug Interactions; Drug Therapy, Combination; Humans; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome | 2004 |
The risk of harm in mania and the very early time course of improvement: important but neglected variables in treatment research.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Humans; Olanzapine; Piperazines; Quality of Life; Quinolones; Risk Factors; Self-Injurious Behavior; Thiazoles | 2004 |
Prolactin elevation with ziprasidone.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Comorbidity; Depression, Postpartum; Dibenzothiazepines; Female; Humans; Hyperprolactinemia; Piperazines; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Ziprasidone monotherapy in pediatric bipolar disorder.
Topics: Adolescent; Bipolar Disorder; Child; Female; Humans; Male; Piperazines; Thiazoles | 2004 |
The use of two neuroleptics to treat bipolar illness in two children.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Bipolar Disorder; Child; Drug Therapy, Combination; Humans; Male; Olanzapine; Piperazines; Thiazoles | 2004 |
Molecular studies probe bipolar disorder.
Topics: Animals; Benzothiazoles; Bipolar Disorder; Carrier Proteins; Central Nervous System Agents; DNA-Binding Proteins; Gene Expression Regulation; Genes, bcl-2; Humans; Lithium Carbonate; Neuronal Plasticity; Pramipexole; Signal Transduction; Thiazoles; Transcription Factors; Valproic Acid | 2005 |
Pramipexole, ropinirole, and mania in Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Indoles; Levodopa; Parkinson Disease; Pramipexole; Thiazoles | 2005 |
The highest intentional ziprasidone overdose was not fatal.
Topics: Antipsychotic Agents; Bipolar Disorder; Drug Overdose; Female; Humans; Intention; Middle Aged; Piperazines; Suicide, Attempted; Thiazoles | 2005 |
Ziprasidone and hypomania.
Topics: Bipolar Disorder; Humans; Piperazines; Serotonin Antagonists; Thiazoles | 2005 |
Ziprasidone-induced priapism requiring surgical treatment.
Topics: Adult; Bipolar Disorder; Erectile Dysfunction; Humans; Male; Piperazines; Priapism; Psychotic Disorders; Thiazoles | 2006 |
Sudden akathisia after a ziprasidone dose reduction.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Piperazines; Substance Withdrawal Syndrome; Thiazoles | 2006 |
Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Costs; Drug Prescriptions; Drug Utilization Review; Episode of Care; Follow-Up Studies; Humans; Insurance Claim Review; International Classification of Diseases; Middle Aged; Olanzapine; Patient Compliance; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; Treatment Outcome | 2006 |
Ziprasidone-induced acute dystonic reactions in patients with bipolar disorder.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Male; Piperazines; Thiazoles | 2006 |
Pramipexole: augmentation in the treatment of depressive symptoms.
Topics: Adult; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder, Major; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Pramipexole; Somatoform Disorders; Thiazoles | 2006 |
Injectable atypical antipsychotics for agitation in borderline personality disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Emergency Services, Psychiatric; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome | 2006 |
Ziprasidone in bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lithium Compounds; Piperazines; Practice Guidelines as Topic; Thiazoles | 2006 |
Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.
Topics: Acetylcholine; Adult; Ambulatory Care; Bipolar Disorder; Brain; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyridines; Radioligand Assay; Receptor, Muscarinic M2; Synapses; Thiazoles; Tissue Distribution | 2006 |
Advanced pediatric psychopharmacology.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal | 2006 |
Does antipsychotic polypharmacy increase the risk for metabolic syndrome?
Topics: Adult; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Mass Index; Cholesterol, HDL; Clozapine; Cross-Sectional Studies; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Piperazines; Quetiapine Fumarate; Quinolones; Risk Factors; Schizophrenia; Thiazoles; Triglycerides | 2007 |
Atypical antipsychotic drug-induced acute laryngeal dystonia: 2 case reports.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Dystonia; Humans; Laryngeal Diseases; Male; Middle Aged; Piperazines; Thiazoles | 2007 |
Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Therapy; Female; Hospitalization; Humans; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles | 2007 |
Ziprasidone-associated mania in a case of obssessive-compulsive disorder.
Topics: Anticonvulsants; Bipolar Disorder; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles | 2007 |
Practical strategies for assessing and stabilizing bipolar patients in urgent situations.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Emergency Services, Psychiatric; Humans; Impulsive Behavior; Injections, Intramuscular; Olanzapine; Piperazines; Practice Guidelines as Topic; Quinolones; Risperidone; Suicide, Attempted; Thiazoles; Time Factors | 2007 |
Ziprasidone-induced hyperprolactinemia: a case report.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Hyperprolactinemia; Piperazines; Thiazoles | 2008 |
High-dose ziprasidone monotherapy in bipolar I disorder patients with depressed or mixed episodes.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Treatment Outcome | 2008 |
Pramipexole in refractory bipolar depression.
Topics: Adult; Antipsychotic Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Middle Aged; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles | 1999 |
Pramipexole treatment for cocaine cravings.
Topics: Adult; Antidepressive Agents; Behavior, Addictive; Benzothiazoles; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Diagnosis, Dual (Psychiatry); Dopamine Agonists; Drug Therapy, Combination; Humans; Lamotrigine; Male; Pramipexole; Thiazoles; Treatment Outcome; Triazines | 1999 |
Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
Topics: Adult; Benzothiazoles; Bipolar Disorder; Depressive Disorder; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2000 |
Pramipexole for depression.
Topics: Adult; Antidepressive Agents; Benzothiazoles; Bipolar Disorder; Depressive Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pramipexole; Thiazoles; Treatment Outcome | 2002 |
Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited.
Topics: Anticonvulsants; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Female; Fructose; Humans; Lamotrigine; Male; Obesity; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Triazines | 2002 |
Ziprasidone induction of hypomania in depression?
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Piperazines; Recurrence; Thiazoles | 2002 |